Miravant Medical Technologies (MRVT/MRVT.PK) Wrap Up:

Miravant Medical Technologies engages in the research and development of drugs and medical device products for use in photodynamic therapy. It also manufactures light producing and light delivery devices. The company’s drugs when activated by light induce a photochemical reaction in the presence of oxygen that can be used to destroy diseased cells and abnormal blood vessels. Its drugs and devices are in various stages of development, which include PHOTREX, a phase III clinical trial product, to be used for the treatment of wet age-related macular degeneration or AMD; MV9411, a phase II clinical trial product, for the treatment of plaque psoriasis; and MV0633, an advanced preclinical stage pr...